三、结论
神经影像学检查有助于更早期的为神经退行性痴呆患者和认知能力下降患者进行准确的诊断和判断预后。AD 患者存在一个有序的影像生物标志物的变化过程,即疾病早期出现淀粉样蛋白PET显像的异常,随后MRI 结构成像和18F-FDG PET 显像的定量测定可以发现神经变性的各种异常[22]。以后的研究有必要进一步验证,联合多种生物标志物来提高诊断准确度。选择适当的、多模态MRI 影像和PET 影像有可能改善神经退行性痴呆患者的诊断和管理。
参考文献
[1]Herholz K.Perfusion SPECT and FDG-PET[J].Int Psychogeriatrics,2011,23(Suppl 2):S25-S31.
[2]Thomas JB,Brier MR,Bateman RJ,et al.Functional connectivity in autosomal dominant and late-onset Alzheimer disease[J].JAMA Neurol,2014,71(9):1111-1122.
[3]Panegyres PK,Rogers JM,McCarthy M,et al.Fluorodeoxyglucose -positron emission tomography in the differential diagnosis of early-onset dementia:a prospective,community-based study[J].BMC Neurol,2009,9:41.
[4]Clark CM,Pontecorvo MJ,Beach TG,et al.Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques:a prospective cohort study[J].Lancet Neurol,2012,11(8):669-678.
[5]Chien DT,Bahri S,Szardenings AK,et al.Early clinical PET imaging results with the novel PHF-tau radioligand[F-18]-T807[J].J Alzheimers Dis,2013,34(2):457-468.
[6]Fodero-Tavoletti MT,Okamura N,Furumoto S,et al.18 F-THK523:a novel in vivo tau imaging ligand for Alzheimer's disease[J].Brain,2011,134(Pt 4):1089-1100.
[7]Arriagada PV,Growdon JH,Hedley-Whyte ET,et al.Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease[J].Neurology,1992,42(3 Pt 1):631-639.
[8]Kreisl WC,Lyoo CH,McGwier M,et al.In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease[J].Brain,2013,136(Pt 7):2228-2238.
[9]Fjell AM,Walhovd KB,Fennema-Notestine C,et al.One-year brain atrophy evident in healthy aging[J].J Neurosci,2009,29(48):15223-15231.
[10]Nosheny RL,Insel PS,Truran D,et al.Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment[J].Neurobiol Aging,2015,36(1):273-282.
[11]Rowe CC,Ellis KA,Rimajova M,et al.Amyloid imaging results from the Australian imaging,biomarkers and lifestyle(AIBL)study of aging[J].Neurobiol Aging,2010,31(8):1275-1283.
[12]McKhann GM,Knopman DS,Chertkow H,et al.The diagnosis of dementia due to Alzheimer's disease:recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease[J].Alzheimers Dement,2011,7(3):263-269.
[13]Albert MS,DeKosky ST,Dickson D,et al.The diagnosis of mild cognitive impairment due to Alzheimer's disease:recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease[J].Alzheimers Dement,2011,7(3):270-279.
[14]Sperling RA,Aisen PS,Beckett LA,et al.Toward defining the preclinical stages of Alzheimer's disease:recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease[J].Alzheimers Dement,2011,7(3):280-292.
[15]Shi F,Liu B,Zhou Y,et al.Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease:meta-analyses of MRI studies[J].Hippocampus,2009,19(11):1055-1064.
[16]Yushkevich PA,Pluta JB,Wang H,et al.Automated volumetry and regional thickness analysis of hippocampal subfields and medial temporal cortical structures in mild cognitive impairment[J].Hum Brain Mapp,2015,36(1):258-287.
[17]Da X,Toledo JB,Zee J,et al.Integration and relative value of biomarkers for prediction of MCI to AD progression:spatial patterns of brain atrophy,cognitive scores,APOE genotype and CSF biomarkers[J].Neuroimage Clin,2014,4:164-173.(https://www.daowen.com)
[18]Minoshima S,Giordani B,Berent S,et al.Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease[J].Ann Neurol,1997,42(1):85-94.
[19]Kadir A,Almkvist O,Forsberg A,et al.Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease[J].Neurobiol Aging,2012,33(1):198e1-e14.
[20]Jack CR Jr,Knopman DS,Jagust WJ,et al.Tracking pathophysiological processes in Alzheimer ' s disease:an updated hypothetical model of dynamic biomarkers[J].Lancet Neurol,2013,12(2):207-216.
[21]Teune LK,Bartels AL,de Jong BM,et al.Typical cerebral metabolic patterns in neurodegenerative brain diseases[J].Mov Disord,2010,25(14):2395-2404.
[22]Koedam EL,Lauffer V,van der Vlies AE,et al.Early-versus late-onset Alzheimer's disease:more than age alone[J].J Alzheimers Dis,2010,19(4):1401-1408.
[23]Migliaccio R,Agosta F,Rascovsky K,et al.Clinical syndromes associated with posterior atrophy:early age at onset AD spectrum[J].Neurology,2009,73(19):1571-1578.
[24]McKeith IG.Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies(DLB):report of the Consortium on DLB International Workshop[J].J Alzheimers Dis,2006,9(3 Suppl):417-423.
[25]Edison P,Rowe CC,Rinne JO,et al.Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with[11C]PIB positron emission tomography[J].J Neurol Neurosurg Psychiatry,2008,79(12):1331-1338.
[26]Whitwell JL,Weigand SD,Shiung MM,et al.Focal atrophy in dementia with Lewy bodies on MRI:a distinct pattern from Alzheimer's disease[J].Brain,2007,130(Pt 3):708-719.
[27]Gilman S,Koeppe RA,Little R,et al.Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with[18 F]fluorodeoxyglucose and neuropsychological testing[J].Exp Neurol,2005,191(Suppl 1):S95-S103.
[28]Papathanasiou ND,Boutsiadis A,Dickson J,et al.Diagnostic accuracy of[I-123]-FP-CIT(DaTSCAN)in dementia with Lewy bodies:a meta-analysis of published studies[J].Parkinsonism Relat Disord,2012,18(3):225-229.
[29]Pereira JM,Williams GB,Acosta-Cabronero J,et al.Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration[J].Neurology,2009,72(19):1653-1660.
[30]Jeong Y,Cho SS,Park JM,et al.18 F-FDG PET findings in frontotemporal dementia:an SPM analysis of 29 patients[J].J Nucl Med,2005,46(2):233-239.
[31]Nestor PJ,Fryer TD,Hodges JR.Declarative memory impairments in Alzheimer's disease and semantic dementia[J].Neuroimage,2006,30(3):1010-1020.
[32]Poljansky S,Ibach B,Hirschberger B,et al.A visual[18 F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration[J].Eur Arch Psychiatry Clin Neurosci,2011,261(6):433-446.
[33]Villemagne VL,Ong K,Mulligan RS,et al.Amyloid imaging with 18 Fflorbetaben in Alzheimer disease and other dementias[J].J Nucl Med,2011,52(8):1210-1217.
[34]Kitagaki H,Hirono N,Ishii K,et al.Corticobasal degeneration:evaluation of cortical atrophy by means of hemispheric surface display generated withMR images[J].Radiology,2000,216(1):31-38.
[35]Wadia PM,Lang AE.The many faces of corticobasal degeneration[J].Parkinsonism Relat Disord,2007,13(Suppl 3):S336-S340.
(陆小伟)